NonprofitsAmerican Association For The Study Of Liver Diseases Foundation

Health Care

American Association For The Study Of Liver Diseases Foundation

ALEXANDRIA, VA

Total revenue

$24.3M

Total expenses

$4.1M

Net assets

$35.9M

Grants received

$7.6M

28 grants

EIN

464495751

Tax year

2023

Mission

See part iii, line 1

Programs

3 programs

Liver leaders council: the liver leaders council (llc) is a corporate partnership program launched by the aasld foundation in 2023 which will engage industry partners annually through a portfolio of benefits, services, and strategic stakeholder conversations offered by both aasld and the aasld foundation.in addition to a portfolio of discounts, event participation opportunities and branding, the liver leaders council will meet twice per year (spring- in conjunction with digestive diseases week and fall- at the liver meeting) for an exclusive liver leaders council summit. These meetings will be focused on emerging issues across the spectrum of liver disease, bringing together industry, member-leader experts, regulators, and patients/patient advocacy groups to engage in strategic conversations around shared opportunities and challenges.

Expenses: $235K

Emerging liver scholars: the emerging liver scholars (els) program promotes the study of hepatology among medical, surgical and pediatric residents who have the potential for a career in academic medicine and who haven't yet determined their longterm career goals. The els program is supported by aasld and aasld foundation as part of its continuing mission to inspire and invest in the next generation of hepatologists.

Expenses: $133K

Public awareness: the foundation works to increase public awareness of liver disease by maintaining information on its website aasldfoundation.org, and by exhibiting and distributing information at meetings and conventions focused on liver disease.

Expenses: $132K

Financials

FY 2023

Revenue

Contributions & grants$23.9M
Program service revenue
Investment income$471K
Other revenue
Total revenue$24.3M

Expenses

Grants paid$2.4M
Salaries & benefits$799K
Fundraising$323K
Other expenses$869K
Total expenses$4.1M
Total assets$39.5M
Net assets$35.9M

People

13 listed

NameRoleCompensation

BRUCE LUXON

CHAIR (UNTIL 12/2023)

Board

$15K

5 hrs/wk

TAMAR H TADDEI

TREASURER

Board

5 hrs/wk

KIMBERLY ANN BROWN

TRUSTEE (UNTIL 01/2024), CHAIR

Board

5 hrs/wk

GRACE L SU

TRUSTEE (UNTIL 01/2024), VICE-CHAIR

Board

5 hrs/wk

DAVID E BERNSTEIN

TRUSTEE

Board

5 hrs/wk

GUADALUPE GARCIA-TASO

TRUSTEE

Board

5 hrs/wk

SAUL J KARPEN

TRUSTEE

Board

5 hrs/wk

MICHAEL LUCEY

TRUSTEE

Board

5 hrs/wk

MATTHEW D'UVA

CHIEF EXECUTIVE OFFICER

Board

7 hrs/wk

JULIE DEAL

EXECUTIVE DIRECTOR

Board

15 hrs/wk

MUKARAB ISLAM

VP, FINANCE AND ADMINISTRATION

Board

0.4 hrs/wk

W RAY KIM

VICE-CHAIR (UNTIL 12/2023)

Board

5 hrs/wk

MARJORIE BYNUM

CHIEF OF STAFF

Staff

2.5 hrs/wk

Grants received

Showing 28 of 28

FromAmountPurposeYear
$5K
GENERAL SUPPORT
2024
$1.2M
INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE, PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS, PROVIDE FUNDING FOR TRAVEL AWARDS EXPENSES
2023
$110K
For grant recipient's exempt purposes
2023
$75K
GENERAL PURPOSES
2023
$13K
UNRESTRICTED
2023
$1.2M
TO INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE; TO PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS; PROVIDE FUNDING FOR TRAVEL AWARDS EXPENSES
2022
$105K
For grant recipient's exempt purposes
2022
$9K
UNRESTRICTED
2022
$1.0M
TO INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE.
2021
$68K
For grant recipient's exempt purposes
2021
$68K
For grant recipient's exempt purposes
2021
$11K
UNRESTRICTED
2021
$1M
TO INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE.
2020
$65K
For grant recipient's exempt purposes
2020
$10K
Unrestricted
2020
$4K
MATCHING GIFTS
2020
$1.2M
TO INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE, PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS AND PROVIDE FUNDING FOR PUBLIC AWARENESS EXPENSES.
2019
$8K
For grant recipient's exempt purposes
2019
$188K
For grant recipient's exempt purposes
2018
$5K
PROGRAM SUPPORT
2018
$100
Matching Grant
2018
$1.1M
TO INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE, PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS AND PROVIDE FUNDING FOR PUBLIC AWARENESS EXPENSES.
2017
$6K
HEALTH & HUMAN SERVICES
2017

Funded by

$7.6M from 10 funders · 28 grants · 2017–2024

American Association For The Study

$6.7M · 6 grants · 2017–2023

Fidelity Investments Charitable Gift Fund

$613K · 7 grants · 2018–2023

Liver Institute And Foundation For

$75K · 1 grant · 2023

California Community Foundation

$50K · 1 grant · 2021

Network For Good

$43K · 4 grants · 2020–2023

Donor Advised Charitable Giving Inc

$42K · 5 grants · 2017–2023

Paypal Charitable Giving Fund

$5K · 1 grant · 2024

Give Back Foundation

$5K · 1 grant · 2018

Details

EIN464495751
NTEE codeE11
Subsection03
Ruling date2015-09
Formed2013
Employees0
Volunteers60
AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION — Mission, Financials & Grants Received | Grantivo